[Cl:1][C:2]1[CH:14]=[CH:13][C:5]([O:6][CH2:7][C:8]([O:10]CC)=[O:9])=[C:4]([CH2:15][N:16]2[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]2)[CH:3]=1.[S:22](Cl)(Cl)(=[O:24])=[O:23].[OH-].[Na+].[C:29](O)(=O)[CH3:30]>C1COCC1.C(N(CC)CC)C>[Cl:1][C:2]1[CH:14]=[CH:13][C:5]([O:6][CH2:7][C:8]([OH:10])=[O:9])=[C:4]([CH2:15][N:16]2[CH2:17][CH2:18][N:19]([S:22]([C:30]3[CH:29]=[CH:4][CH:3]=[CH:2][CH:14]=3)(=[O:24])=[O:23])[CH2:20][CH2:21]2)[CH:3]=1The product of example 11 part b (300 mg) was dissolved in THF (10 ml) and triethylamine (0.28 ml). The sulfonyl chloride (1.1 equivalents) was added and stirred for 3 h. 1M NaOH (3 ml) was added and stirred for 2 hours. Acetic acid (5 ml) was added and then the reaction mixture was concentrated in vacuo. The residue was further purified by RPHPLC to give the sub-title compound (0.19 g).
読み込み中…